Search results

1. AstraZeneca goes early with Gracell

   … prior lines) 162 (80 per ct.gov) 100% ORR (n=15) at ASH 2025; more data expected 2027 Durga-2 …

   
    

   Jacob Plieth
    
   - 02/12/2026 - 14:38

2. ImmuneOnco takes a second project pivotal

   … MAb + Revlimid, uncontrolled DLT & MTD Data at ASH 2025: 91% ORR & 68% CRR in 34 pts in ph2 at 1.6mg/kg …

   
    

   Madeleine Armstrong
    
   - 02/03/2026 - 14:04

3. J&J claims another second-line Tecvayli win

   … MAb + Darzalex, vs DPd or DVd PFS Data at ASH 2025: 83% reduction in risk of progression/death; 54% …

   
    

   Madeleine Armstrong
    
   - 01/16/2026 - 16:27

4. ASH 2025 – Kelonia gets another response

   ASH 2025 – Kelonia gets another response …

   
    

   Madeleine Armstrong
    
   - 12/09/2025 - 15:38

5. ASH 2025 – Cullinan finds its new purpose in FLT3

   ASH 2025 – Cullinan finds its new purpose in FLT3 …

   
    

   Jacob Plieth
    
   - 12/09/2025 - 15:38

6. ASH 2025 – Terns wins

   ASH 2025 – Terns wins Full story …

   
    

   Jacob Plieth
    
   - 12/10/2025 - 18:04

7. ASH 2025 – J&J’s multiple myeloma juggling act

   ASH 2025 – J&J’s multiple myeloma juggling act …

   
    

   Madeleine Armstrong
    
   - 12/10/2025 - 10:41

8. ASH 2025 – Adcetris good, follow-ons not so much

   ASH 2025 – Adcetris good, follow-ons not so much … phase 1 dataset has evolved   EHA 2025 ASH 2025 Cutoff 4 Mar 2025 10 Sep 2025 …

   
    

   Jacob Plieth
    
   - 12/09/2025 - 15:38

9. ASH 2025 – Regeneron’s Lynozyfic shows front-line promise

   ASH 2025 – Regeneron’s Lynozyfic shows front-line …

   
    

   Madeleine Armstrong
    
   - 12/10/2025 - 10:05

10. ASH 2025 – Gilead spills the beans on “fast” Car-T

    ASH 2025 – Gilead spills the beans on “fast” Car-T …

    
     

    Jacob Plieth
     
    - 12/09/2025 - 15:39